Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism OTUB1 inhibitors(OTU deubiquitinase, ubiquitin aldehyde binding 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC43H44F2N6O8 |
InChIKeyGBRJFUUBXKOHMN-UHFFFAOYSA-N |
CAS Registry2858812-70-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Microsatellite Instability cancer | Preclinical | United States | 18 Sep 2021 |